K.-L.G. Spindler

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer

K.-L.G. Spindler, Niels Pallisgaard, Rikke Fredslund Andersen et al. · PLoS ONE · 2015 · 120 citations · Full text

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer

K.-L.G. Spindler, Niels Pallisgaard, Audrey Rasmussen et al. · Annals of Oncology · 2009 · 75 citations · Full text

Kras Mutations, G Polymorphism, Gastrointestinal Oncology +9

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

Anna Johnsson, Helga Hagman, Jan‐Erik Frödin et al. · Annals of Oncology · 2013 · 74 citations · Full text

Gastrointestinal Oncology, Medicine, Colorectal Cancer +8

Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer

Jakob Vasehus Schou, Finn Ole Larsen, Brita Singers Sørensen et al. · Annals of Oncology · 2017 · 74 citations

Surgical Oncology, Radiation Therapy, Medicine +8

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

Julian Hamfjord, Tormod Kyrre Guren, Olav Dajani et al. · Annals of Oncology · 2019 · 74 citations · Full text

Medicine, Pathology, Colorectal Cancer +7